#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal dystrophy Propionic acidaemia T-cell lymphoma Cutaneous T-cell lymphoma Neurodevelopmental disorder Chronic myeloid leukaemia Bronchopulmonary dysplasia Prader-Willi syndrome Optic ischaemic neuropathy Central nervous system neoplasm Retinoblastoma Craniopharyngioma Antiphospholipid syndrome Glomerulonephritis rapidly progressive Acute graft versus host disease in skin More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria – Basic Information Netherton’s syndrome – Treatment Loeys-Dietz syndrome – Trials in Disease Mucopolysaccharidosis Paraneoplastic neurological syndrome – Basic Information Factor IX deficiency – Trials in Disease Systemic sclerosis pulmonary Burkitt’s lymphoma – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Hereditary optic atrophy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Loperamide Hydrochloride Ecoo18A Onasemnogene Abeparvovec Oxytocin Vidutolimod Nelivaptan Thymalfasin 68Ganota-Anti-Her2 Vhh1 Phenol Bay 3283142 Caffeine Vb10.16 Isoprenaline Hydrochloride Rifampicin Eteplirsen Iopamidol Clopidogrel Hydrogen Sulfate Pegvaliase Teverelix Emtricitabine More therapies…

    Learn about Your Condition

    Leiomyosarcoma metastatic Colon cancer metastatic Primary adrenal insufficiency Anaemia of pregnancy Bladder cancer Lupus nephritis Glaucoma Systemic infection End stage renal disease Intestinal obstruction Gestational diabetes Hypervolaemia Glomerulonephritis membranous Hypertrophic scar Obstructive airways disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Enzalutamide
    • Prednisolone
    Austria Belgium Czechia Denmark Finland France +9

  • Study on the Effectiveness of Moxifloxacin and Drug Combination for Treating Bone Implant Infections in Patients with Long Bone Fractures

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Amoxicillin Sodium
    • Ampicillin
    Spain

  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphoma
    • Mesothelioma malignant
    • Transitional cell carcinoma
    Investigated Drugs:
    • Tulmimetostat
    • Enzalutamide
    France Italy Poland Spain

  • Study on Colon Cancer Treatment Using Disodium Levofolinate and Drug Combination for Patients with Operable Stage III and High-Risk Stage II Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer stage II
    • Colorectal cancer stage III
    Investigated Drugs:
    • Disodium Levofolinate
    • Panitumumab
    • Pertuzumab
    Germany Italy Spain

  • Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Degarelix
    • Leuprorelin Acetate
    Belgium France Ireland Spain

  • Study of Talazoparib and Enzalutamide combination treatment for patients with metastatic prostate cancer who previously received Abiraterone

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Talazoparib
    • Enzalutamide
    France Spain

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Erdafitinib
    • Mitomycin
    • Gemcitabine Hydrochloride
    Austria Belgium Czechia Denmark France Germany +4

  • Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Glycopyrronium Bromide
    • Salbutamol
    • Fluticasone Propionate
    Bulgaria Hungary Poland Spain

  • Study on the Effectiveness and Safety of Riliprubart Compared to Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Riliprubart
    Belgium Czechia Denmark France Germany Greece +7

  • Study on the Effectiveness and Safety of Prednisone for Patients with Drug-Induced Liver Injury (DILI)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hepatotoxicity
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Prednisone
    Spain
Previous Page
1 … 6 7 8 9 10 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!